Does endogenous serum oestrogen play a role in meibomian gland dysfunction in postmenopausal women with dry eye?

British Journal of Ophthalmology

Volumn 101, Issue 2, 2017, Pages 218-222

  Golebiowski, Blanka ^a   Badarudin, Noor ^a   Eden, John ^a,b   You, Jingjing ^a,c   Hampel, Ulrike ^a,d   Stapleton, Fiona ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ROYAL HOSPITAL FOR WOMEN   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Eye Lids; Ocular surface; Tears

Indexed keywords

ANDROSTANEDIOL; ESTRADIOL; ESTROGEN; PRASTERONE SULFATE;

ADULT; AGE; AGED; BLOOD SAMPLING; CLINICAL ARTICLE; CONFERENCE PAPER; CONJUNCTIVA; CORNEA; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DRY EYE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTROGEN BLOOD LEVEL; FEMALE; HUMAN; LACRIMATION; MEIBOMIAN GLAND; MEIBOMIAN GLAND DYSFUNCTION; MIDDLE AGED; MULTIPLE LINEAR REGRESSION ANALYSIS; MULTIVARIATE ANALYSIS; OCULAR COMFORT INDEX; OCULAR SURFACE DISEASE INDEX; POSTMENOPAUSE; PREDICTION; TEAR OSMOLARITY; TELANGIECTASIA; VENOUS BLOOD; VERY ELDERLY; VISUAL SYSTEM EXAMINATION; BLOOD; DRY EYE SYNDROMES; LACRIMAL FLUID; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REGRESSION ANALYSIS;

AGED; AGED, 80 AND OVER; CONJUNCTIVA; CROSS-SECTIONAL STUDIES; DRY EYE SYNDROMES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTROGENS; FEMALE; HUMANS; MEIBOMIAN GLANDS; MIDDLE AGED; POSTMENOPAUSE; REGRESSION ANALYSIS; TEARS;

EID: 84964655267     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2016-308473     Document Type: Article

References (35)

1. Moss SE, Klein R, Klein BEK. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 2000;118:1264-8.
2. [No authors listed]. The Epidemiology of Dry Eye Disease: Report of the Epidemiology Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf 2007;5:93-107.
3. Chia E-M, Mitchell P, Rochtchina E, et al. Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study. Clin Experiment Ophthalmol 2003;31:229-32.
4. Schaumberg DA, Sullivan DA, Buring JE, et al. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003;136:318-26.
5. Truong S, Cole N, Stapleton F, et al. Sex hormones and the dry eye. Clin Exp Optom 2014;97:324-36.
6. Sullivan DA, Kelleher RS, Vaerman JP, et al. Androgen regulation of secretory component synthesis by lacrimal gland acinar cells in vitro. J Immunol 1990;145:4238-44.
7. Sullivan DA, Sullivan BD, Ullman MD, et al. Androgen influence on the meibomian gland. Invest Ophthalmol Vis Sci 2000;41:3732-42.
8. Sullivan, DA, Sullivan BD, Evans JE, et al. Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye. Ann N Y Acad Sci 2002;966:211-22.
9. Krenzer KL, Dana MR, Ullman MD, et al. Effect of androgen deficiency on the human meibomian gland and ocular surface. J Clin Endocrinol Metab 2000;85:4874-82.
10. Cermak JM, Krenzer KL, Sullivan RM, et al. Is complete androgen insensitivity syndrome associated with alterations in the meibomian gland and ocular surface? Cornea 2003;22:516-21.
11. Schaumberg, DA, Buring JE, Sullivan DA, et al. Hormone Replacement Therapy and Dry Eye Syndrome. JAMA 2001;286:2114-19.
12. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
13. Schiffman, RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the ocular surface diseases index. Arch Ophthalmol 2000;118:615-21.
14. Johnson ME, Murphy PJ. Measurement of Ocular Surface Irritation on a Linear Interval Scale with the Ocular Comfort Index. Invest Ophthalmol Vis Sci 2007;48:4451-8.
15. Yamaguchi M, Kutsuna M, Uno T, et al. Marx line: fluorescein staining line on the inner lid as indicator of meibomian gland function. Am J Ophthalmol 2006;141:669-75.
16. Foulks GN, Bron AJ. Meibomian Gland Dysfunction: A Clinical Scheme for Description, Diagnosis, Classification, and Grading. Ocul Surf 2003;1:107-26.
17. Lemp MA, Bron AJ, Baudouin C, et al. Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol 2011;151:792-8.
18. Srinivasan S, Joyce E, Senchyna M, et al. Clinical signs and symptoms in post-menopausal females with symptoms of dry eye. Ophthalmic Physiol Opt 2008;28:365-72.
19. Chao C, Golebiowski B, Cui Y, et al. Development of a Chinese version of the Ocular Comfort Index. Invest Ophthalmol Vis Sci 2014;55:3562-71.
20. Doughty MJ, Whyte J, Li W. The phenol red thread test for lacrimal volume--does it matter if the eyes are open or closed? Ophthalmic Physiol Opt 2007;27:482-9.
21. Hykin PG, Bron AJ. Age-related morphological changes in lid margin and meibomian gland anatomy. Cornea 1992;11:334-42.
22. Bartlett JD, Keith MS, Sudharshan L, et al. Associations between signs and symptoms of dry eye disease: a systematic review. Clin Ophthalmol 2015;9:1719-30.
23. Schaumberg DA, Nichols JJ, Papas EB, et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Invest Ophthalmol Vis Sci 2011;52:1994-2005.
24. Stomati M, Monteleone P, Casarosa E, et al. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause. Gynecol Endocrinol 2000;14:342-63.
25. Davison SL, Bell R, Donath S, et al. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005;90:3847-53.
26. Labrie F, Bélanger A, Bélanger P, et al. Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. J Steroid Biochem Mol Biol 2006;99:182-8.
27. Tomlinson A, Bron AJ, Korb DR, et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci 2011;52:2006-49.
28. Sullivan BD, Whitmer D, Nichols KK, et al. An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci 2010;51:6125-30.
29. Labrie F. Intracrinology. Mol Cell Endocrinol 1991;78:C113-18.
30. Wang SB, Hu KM, Seamon KJ, et al. Estrogen negatively regulates epithelial wound healing and protective lipid mediator circuits in the cornea. FASEB J 2012;26:1506-16.
31. Suzuki T, Schirra F, Richards SM, et al. Estrogen and Progesterone Control of Gene Expression in the Mouse Meibomian Gland. Invest Ophthalmol Vis Sci 2008;49:1797-808.
32. Kam W, Sullivan D. Suppressive effects of 17β-estradiol on immortalized human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci 2013;54:E-Abstract 4316.
33. Sullivan BD, Evans JE, Krenzer KL, et al. Impact of antiandrogen treatment on the fatty acid profile of neutral lipids in human meibomian gland secretions. J Clin Endocrinol Metab 2000;85:4866-73.
34. Stanczyk FZ, Lee JS, Santen RJ. Standardization of Steroid Hormone Assays: Why, How, and When? Cancer Epidemiol Biomarkers Prev 2007;16:1713-19.
35. Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 2003;22:7:640-50.